Establishment of radioimmunoassay for human islet amyloid polypeptide and its tissue content and plasma concentration

https://doi.org/10.1016/0006-291X(89)91732-4Get rights and content

Abstract

Using a synthetic C- terminal tetradecapeptide of human islet amyloid polypeptide (IAPP), we prepared an antiserum for human IAPP [24–37] and established a highly sensitive radioimmunoassay (RIA) for human IAPP. Analyses of human pancreatic extract using reverse-phase high performance liquid chromatography coupled with the RIA revealed that the antiserum specifically detects human IAPP. The content of IAPP in the pancreas of two non-diabetic patients was 604.0 and 1447.7 pg/mg wet weight, and a small amount of IAPP-immunoreactivity was detected in the stomach, duodenum, and jejunum. The mean plasma concentration of IAPP in 10 normal individuals was 13.5 ± 4.8 (SD) pg/ml. The RIA established in this study provides a useful tool to elucidate the physiological function of IAPP and its pathophysiological significance in non-insulin-dependent diabetes mellitus (NIDDM).

References (16)

  • A.L. Maloy et al.

    Human Pathol

    (1981)
  • P. Westermark et al.

    Biochem. Biophys. Res. Commun

    (1986)
  • A. Clark et al.

    Lancet

    (1987)
  • S. Mosselman et al.

    FEBS Lett

    (1988)
  • T. Sanke et al.

    J. Biol. Chem

    (1988)
  • K. Kangawa et al.

    Biochem. Biophys. Res. Commun

    (1984)
  • E.T. Bell

    Am. J. Pathol

    (1955)
  • P. Westermark et al.

    Lab. Invest

    (1977)
There are more references available in the full text version of this article.

Cited by (0)

†

Present address: National Cardiovascular Center Research Institute, Suita, Osaka 565, Japan.

View full text
Copyright © 1989 Published by Elsevier Inc.